Cargando…
Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells
Despite decades of effort to develop effective therapy and to identify promising new drugs, prostate cancer is lethal once it progresses to castration-resistant disease. Studies show mis-regulation of multiple pathways in castration-resistant prostate cancer (CRPC), reflecting the heterogeneity of t...
Autores principales: | Lee, Eugine, Ha, Susan, Logan, Susan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624871/ https://www.ncbi.nlm.nih.gov/pubmed/26509262 http://dx.doi.org/10.1371/journal.pone.0141589 |
Ejemplares similares
-
Phosphorylation of the Androgen Receptor by PIM1 in Hormone Refractory Prostate Cancer
por: Ha, Susan, et al.
Publicado: (2012) -
Clinical Significance of Wnt/β-Catenin Signalling and Androgen Receptor Expression in Prostate Cancer
por: Jung, Soo Jin, et al.
Publicado: (2013) -
The androgen receptor can signal through Wnt/β-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens
por: Schweizer, Liang, et al.
Publicado: (2008) -
A genome-wide RNA interference screen identifies new regulators of androgen receptor function in prostate cancer cells
por: Imberg-Kazdan, Keren, et al.
Publicado: (2013) -
GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance
por: Lee, Eugine, et al.
Publicado: (2019)